Skip to main content

Advertisement

SpringerLink
Log in

Cost and utilization of blood transfusion associated with spinal surgeries in the United States

  • Original Article
  • Published:
European Spine Journal Aims and scope Submit manuscript

Abstract

The purpose of this study was to examine factors associated with the utilization and cost of blood transfusion during and post-spinal fusion surgery. A retrospective, observational study of 42,029 inpatients undergoing spinal fusion surgery in United States hospitals participating in the PerspectiveTM Comparative Database for inpatient use was conducted. Descriptive analysis, logistic regression, and ordinary least squares (OLS) regression were used to describe the factors associated with the use and cost of allogeneic blood transfusion (ABT). Hospitalization costs were $18,690 (SD=14,159) per patient, erythropoietin costs were $85.25 (SD=3,691.66) per patient, and topical sealant costs were $414.34 (SD=1,020.06) per patient. Sub-analysis of ABT restricted to users revealed ABT costs ranged from $312.24 (SD=543.35) per patient with whole blood to $2,520 (SD=3,033.49) per patient with fresh frozen plasma. Patients that received hypotensive anesthesia (OR,1.61; 95% CI, 1.47–1.77), a volume expander (OR,1.95; 95% CI, 1.75–2.18), autologous blood (OR, 2.04; 95% CI, 1.71–2.42), or an erythropoietic agent (OR=1.64; 95% CI, 1.27–2.12) had a higher risk of ABT. Patients that received cell salvage had a lower risk of transfusion (OR=0.40; 95% CI, 0.32–0.50). Most blood avoidance techniques have low utilization or do not reduce the burden of transfusion associated with spinal fusion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alderman EL, Levy JH, Rich JB, Nili M, Vidne B, Schaff H, Uretzky G, Pettersson G, Thiis JJ, Hantler CB, Chaitman B, Nadel A (1998) Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. J Thorac Cardiovasc Surg 116:716–730

    Article  PubMed  CAS  Google Scholar 

  2. Berenholtz SM, Pronovost PJ, Mullany D, Garrett E, Ness PM, Dorman T, Klag MJ (2002) Predictors of transfusion for spinal surgery in Maryland, 1997 to 2000. Transfusion 42:183–189

    Article  PubMed  Google Scholar 

  3. Blumberg N (1997) Allogeneic transfusion and infection: economic and clinical implications. Semin Hematol 34:34–40

    PubMed  CAS  Google Scholar 

  4. Bryson GL, Laupacis A, Wells GA (1998) Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesth Analg 86:9–15

    Article  PubMed  CAS  Google Scholar 

  5. Carless PA, Henry DA, Moxey AJ, O‘Connell DL, Fergusson DA (2003) Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev:CD001888

  6. Cavallieri S, Riou B, Roche S, Ducart A, Roy-Camille R, Viars P (1994) Intraoperative autologous transfusion in emergency surgery for spine trauma. J Trauma 36:639–643

    PubMed  CAS  Google Scholar 

  7. Domen RE (1998) Adverse reactions associated with autologous blood transfusion: evaluation and incidence at a large academic hospital. Transfusion 38:296–300

    Article  PubMed  CAS  Google Scholar 

  8. Florentino-Pineda I, Thompson GH, Poe-Kochert C, Huang RP, Haber LL, Blakemore LC (2004) The effect of amicar on perioperative blood loss in idiopathic scoliosis: the results of a prospective, randomized double-blind study. Spine 29:233–238

    Article  PubMed  Google Scholar 

  9. Garcia-Huete L, Domenech P, Sabate A, Martinez-Brotons F, Jaurrieta E, Figueras J (1997) The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: a randomized clinical study. Hepatology 26:1143–1148

    Article  PubMed  CAS  Google Scholar 

  10. Gillon J, Thomas MJ, Desmond MJ (1996) Consensus conference on autologous transfusion. Acute normovolaemic haemodilution. Transfusion 36:640–643

    Article  PubMed  CAS  Google Scholar 

  11. Goldman M, Remy-Prince S, Trepanier A, Decary F (1997) Autologous donation error rates in Canada. Transfusion 37:523–527

    Article  PubMed  CAS  Google Scholar 

  12. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP (1999) Transfusion medicine. First of two parts–blood transfusion. N Engl J Med 340:438–447

    Article  PubMed  CAS  Google Scholar 

  13. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP (1999) Transfusion medicine. Second of two parts–blood conservation. N Engl J Med 340:525–533

    Article  PubMed  CAS  Google Scholar 

  14. Helm RE, Klemperer JD, Rosengart TK, Gold JP, Peterson P, DeBois W, Altorki NK, Lang S, Thomas S, Isom OW, Krieger KH (1996) Intraoperative autologous blood donation preserves red cell mass but does not decrease postoperative bleeding. Ann Thorac Surg 62:1431–1441

    Article  PubMed  CAS  Google Scholar 

  15. Herregods L, Moerman A, Foubert L, Den Blauwen N, Mortier E, Poelaert J, Struys M (1997) Limited intentional normovolemic hemodilution: ST-segment changes and use of homologous blood products in patients with left main coronary artery stenosis. J Cardiothorac Vasc Anesth 11:18–23

    Article  PubMed  CAS  Google Scholar 

  16. Hillyer CD, Hart KK, Lackey DA 3rd, Lin LS, Bryan JA (1994) Comparable safety of blood collection in “high-risk” autologous donors versus non-high-risk autologous and directed donors in a hospital setting. Am J Clin Pathol 102:275–277

    PubMed  CAS  Google Scholar 

  17. Iezzoni LI (1997) Assessing quality using administrative data. Ann Intern Med 127:666–674

    PubMed  CAS  Google Scholar 

  18. Innerhofer P, Walleczek C, Luz G, Hobisch-Hagen P, Benzer A, Stockl B, Hessenberger G, Nussbaumer W, Schobersberger W (1999) Transfusion of buffy coat-depleted blood components and risk of postoperative infection in orthopedic patients. Transfusion 39:625–632

    Article  PubMed  CAS  Google Scholar 

  19. Kahraman S, Altunkaya H, Celebioglu B, Kanbak M, Pasaoglu I, Erdem K (1997) The effect of acute normovolemic hemodilution on homologous blood requirements and total estimated red blood cell volume lost. Acta Anaesthesiol Scand 41:614–617

    Article  PubMed  CAS  Google Scholar 

  20. Kaspar M, Ramsay MA, Nguyen AT, Cogswell M, Hurst G, Ramsay KJ (1997) Continuous small-dose tranexamic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation. Anesth Analg 85:281–285

    Article  PubMed  CAS  Google Scholar 

  21. Khambatta HJ, Stone JG, Matteo RS, Michelsen WJ (1978) Hypotensive anesthesia for spinal fusion with sodium nitroprusside. Spine 3:171–174

    Article  PubMed  CAS  Google Scholar 

  22. Kochamba GS, Pfeffer TA, Sintek CF, Khonsari S (1996) Intraoperative autotransfusion reduces blood loss after cardiopulmonary bypass. Ann Thorac Surg 61:900–903

    Article  PubMed  CAS  Google Scholar 

  23. Laupacis A, Fergusson D (1997) Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Anesth Analg 85:1258–1267

    Article  PubMed  CAS  Google Scholar 

  24. Laupacis A, Fergusson D (1998) Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. the international study of peri-operative transfusion (ISPOT) investigators. Transfus Med 8:309–317

    Article  PubMed  CAS  Google Scholar 

  25. Lennon RL, Hosking MP, Gray JR, Klassen RA, Popovsky MA, Warner MA (1987) The effects of intraoperative blood salvage and induced hypotension on transfusion requirements during spinal surgical procedures. Mayo Clin Proc 62:1090–1094

    PubMed  CAS  Google Scholar 

  26. Linden JV, Kruskall MS (1997) Autologous blood: always safer? Transfusion 37:455–456

    Article  PubMed  CAS  Google Scholar 

  27. Munoz JJ, Birkmeyer NJ, Birkmeyer JD, O’Connor GT, Dacey LJ (1999) Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery?: a meta-analysis. Circulation 99:81–89

    PubMed  CAS  Google Scholar 

  28. Nuttall GA, Horlocker TT, Santrach PJ, Oliver WC, Jr., Dekutoski MB, Bryant S (2000) Predictors of blood transfusions in spinal instrumentation and fusion surgery. Spine 25:596–601

    Article  PubMed  CAS  Google Scholar 

  29. Patel NJ, Patel BS, Paskin S, Laufer S (1985) Induced moderate hypotensive anesthesia for spinal fusion and Harrington-rod instrumentation. J Bone Joint Surg Am 67:1384–1387

    PubMed  CAS  Google Scholar 

  30. Peters DC, Noble S (1999) Aprotinin: an update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery. Drugs 57:233–260

    Article  PubMed  CAS  Google Scholar 

  31. Popovsky MA, Whitaker B, Arnold NL (1995) Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Transfusion 35:734–737

    Article  PubMed  CAS  Google Scholar 

  32. Red blood cell transfusions contaminated with Yersinia enterocolitica–United States, 1991–1996, and initiation of a national study to detect bacteria-associated transfusion reactions (1997) MMWR Morb Mortal Wkly Rep 46:553–555

  33. Reitman CA, Watters WC 3rd, Sassard WR (2004) The Cell Saver in adult lumbar fusion surgery: a cost-benefit outcomes study. Spine 29:1580–1583; discussion 1584

    Google Scholar 

  34. Rich JB (1998) The efficacy and safety of aprotinin use in cardiac surgery. Ann Thorac Surg 66:S6–11; discussion S25–18

    Google Scholar 

  35. Sethna NF, Zurakowski D, Brustowicz RM, Bacsik J, Sullivan LJ, Shapiro F (2005) Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology 102:727–732

    Article  PubMed  CAS  Google Scholar 

  36. Sugai Y, Sugai K, Fuse A (2001) Current status of bacterial contamination of autologous blood for transfusion. Transfus Apher Sci 24:255–259

    Article  PubMed  CAS  Google Scholar 

  37. Tang R, Chen HH, Wang YL, Changchien CR, Chen JS, Hsu KC, Chiang JM, Wang JY (2001) Risk factors for surgical site infection after elective resection of the colon and rectum: a single-center prospective study of 2,809 consecutive patients. Ann Surg 234:181–189

    Article  PubMed  CAS  Google Scholar 

  38. Tredwell SJ, Sawatzky B (1990) The use of fibrin sealant to reduce blood loss during Cotrel-Dubousset instrumentation for idiopathic scoliosis. Spine 15:913–915

    Article  PubMed  CAS  Google Scholar 

  39. Triulzi DJ, Vanek K, Ryan DH, Blumberg N (1992) A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion 32:517–524

    Article  PubMed  CAS  Google Scholar 

  40. Trouern-Trend JJ, Cable RG, Badon SJ, Newman BH, Popovsky MA (1999) A case-controlled multicenter study of vasovagal reactions in blood donors: influence of sex, age, donation status, weight, blood pressure, and pulse. Transfusion 39:316–320

    Article  PubMed  CAS  Google Scholar 

  41. Urban MK, Beckman J, Gordon M, Urquhart B, Boachie-Adjei O (2001) The efficacy of antifibrinolytics in the reduction of blood loss during complex adult reconstructive spine surgery. Spine 26:1152–1156

    Article  PubMed  CAS  Google Scholar 

  42. Zheng F, Cammisa FP Jr, Sandhu HS, Girardi FP, Khan SN (2002) Factors predicting hospital stay, operative time, blood loss, and transfusion in patients undergoing revision posterior lumbar spine decompression, fusion, and segmental instrumentation. Spine 27:818–824

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Premier Inc., Pharmaceutical Research Services, Charlotte, NC, USA

    Christopher M. Blanchette, Peter F. Wang & William Saunders

  2. Novo Nordisk Inc., BioPharmaceuticals, Princeton, NJ, USA

    Ashish V. Joshi & Peter Kruse

  3. Novo Nordisk A/S, Global R&D, Bagsvaerd, Denmark

    Mikael Asmussen

Authors
  1. Christopher M. Blanchette
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter F. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ashish V. Joshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mikael Asmussen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. William Saunders
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Peter Kruse
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ashish V. Joshi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blanchette, C.M., Wang, P.F., Joshi, A.V. et al. Cost and utilization of blood transfusion associated with spinal surgeries in the United States. Eur Spine J 16, 353–363 (2007). https://doi.org/10.1007/s00586-006-0066-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00586-006-0066-3

Keywords

Search

Navigation